News and Information

NSI Ventures hits first close on new $125M fund for Southeast Asia

On that note, it announced a first investment from the new vehicle: leading a $5 million Series A fundraise for Biofourmis, a Singapore-based company that has developed a health analytics platform. Aviva co-led the round via its investment arm while Biofourmis announced a partnership with Mayo Clinic.

Read More

Mayo Clinic deal and $5m funding for health data platform Biofourmis

Singapore-based health analytics platform Biofourmis announced the close of its series A funding round today, while also unveiling a partnership with US medical research institute, the Mayo Clinic.

Read More

Biofourmis raises US$5m in Series A funding from NSI Ventures, Aviva Ventures

Biofourmis has raised US$5 million in a Series A round of funding from venture capital firm NSI Ventures and Aviva Ventures, the corporate venture arm of insurer Aviva.

Read More

Biofourmis raises US$5m in Series A funding from NSI Ventures, Aviva Ventures

Biofourmis has raised US$5 million in a Series A round of funding from venture capital firm NSI Ventures and Aviva Ventures, the corporate venture arm of insurer Aviva.

Read More

MAS loosens rules for finance companies to help SMEs raise funds

Finance companies and enterprises welcome raising of regulatory lending caps

Read More

This Singaporean startup wants to save you by predicting medical crises before they arise

This Singaporean startup wants to save you by predicting medical crises before they arise

Read More

Biofourmis raises US$1 million angel funding

Singapore: Biofourmis raises US$1 million angel funding

Read More

Singapore’s Biofourmis raises $1m to bring computing power, AI to manage health-tech data

Singapore’s Biofourmis raises $1m to bring computing power, AI to manage health-tech data

Read More

Health startup firm receives US$1 million boost

SINGAPORE – Health data analytics start-up BioFourmis said Thursday it has received US$1 million (S$1.34 million) in funding from investors SpesNet and Eden Strategy.

Read More

BioFourmis nabs US$1 million in angel funding, aims to provide predictive health insights to its users

Singapore based BioFourmis, the world’s first personalised physiological data analytics firm today announced that the company has secured $1M in angel funding. The investment round was led by SpesNet and Eden Strategy.

Read More

Singaporean analytics startup Biofourmis raises US$1M in angel funding led by SpesNet and Eden Strategy

Biofourmis has been actively working with the healthcare sector to offer predictive, precise and meaningful insights into one’s health

Read More

This startup taps the power of big data analytics to make you healthier

We have more sources of data about our health than ever before – wearables, fitness apps, hospital databases, there’re all kinds of disparate information out there. Singapore-based Biofourmis wants to be the one to organize all that data

Read More

Whether you are a healthcare provider,
payer or pharmaceutical,
biofourmis empowers you

Get In Touch